Chronic Insomnia Market Forecast

DelveInsight’s Chronic Insomnia Market report offers an in-depth understanding of the epidemiology and market trends in the 7MM.

NEVADA, LAS VEGAS, UNITED STATES, April 1, 2024 /EINPresswire.com/ -- The Chronic Insomnia market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Chronic Insomnia pipeline products will significantly revolutionize the Chronic Insomnia market dynamics.

DelveInsight’s “Chronic Insomnia Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the Chronic Insomnia, historical and forecasted epidemiology as well as the Chronic Insomnia market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.

To Know in detail about the Chronic Insomnia market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Chronic Insomnia Market Forecast

Some of the key facts of the Chronic Insomnia Market Report:

The Chronic Insomnia market size was valued approximately USD 333 million in 2021 and is anticipated to grow with a significant CAGR during the study period (2019-2032)

Among the seven major markets (7MM), the United States represented 67.3% of the total market size for Chronic Insomnia in 2021.

In the 7 MM countries, there will be 5,697,127 cases of chronic insomnia that have been diagnosed as of 2021
Age plays a significant role in how the disease develops. The age group of 20 to 29 years saw the highest number of cases in the US in 2021 with 474,746. Following this, there were 421,996 instances in the US for each of the age groups of 30-39 and 40-49 years

France had the greatest diagnosed prevalence of chronic insomnia among the European nations, with 890,539 cases. Germany came in second with 407,108 cases in 2021

Germany reported 207,625 instances of chronic insomnia in females and 199,483 cases in men among the EU5 nations in 2021

Key Chronic Insomnia Companies: Janssen Research & Development, Takeda, and others
Key Chronic Insomnia Therapies: Seltorexant, Ramelteon and zolpidem, and others
The Chronic Insomnia epidemiology based on gender analyzed that Chronic Insomnia is more prominent in females in comparison to males

The Chronic Insomnia market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Chronic Insomnia pipeline products will significantly revolutionize the Chronic Insomnia market dynamics.

Chronic Insomnia Overview
The most prevalent sleep condition, insomnia, has significant socioeconomic implications. Insomnia is defined by difficulty initiating, sustaining, or improving the quality of sleep, according to the International Classification of Sleep Disorders, third edition (ICSD-3). These symptoms cause daytime dysfunction even though there are good sleeping conditions and opportunities.

Get a Free sample for the Chronic Insomnia Market Report:
https://www.delveinsight.com/report-store/chronic-insomnia-market?utm_source=einpresswire&utm_medium=pressrelease&utm_campaign=gpr

Chronic Insomnia Epidemiology
The epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2019 to 2032. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides a detailed analysis of the diagnosed patient pool and future trends.

Chronic Insomnia Epidemiology Segmentation:
The Chronic Insomnia market report proffers epidemiological analysis for the study period 2019–2032 in the 7MM segmented into:
Total Prevalence of Chronic Insomnia
Prevalent Cases of Chronic Insomnia by severity
Gender-specific Prevalence of Chronic Insomnia
Diagnosed Cases of Episodic and Chronic Chronic Insomnia

Download the report to understand which factors are driving Chronic Insomnia epidemiology trends @ Chronic Insomnia Epidemiology Forecast

Chronic Insomnia Drugs Uptake and Pipeline Development Activities

The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Chronic Insomnia market or expected to get launched during the study period. The analysis covers Chronic Insomnia market uptake by drugs, patient uptake by therapies, and sales of each drug.

Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.
The report also covers the Chronic Insomnia Pipeline Development Activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyzes recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.

Chronic Insomnia Therapies and Key Companies
Seltorexant: Janssen Research & Development
Ramelteon and zolpidem: Takeda

Chronic Insomnia Market Drivers
Increasing Prevalence
Personalization of therapies

Chronic Insomnia Market Barriers
Issues with diagnosis and poor knowledge
Use of off-label drugs
High economic burden

Scope of the Chronic Insomnia Market Report
Study Period: 2019–2032
Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan]
Key Chronic Insomnia Companies: Janssen Research & Development, Takeda, and others

Key Chronic Insomnia Therapies: Seltorexant, Ramelteon and zolpidem, and others
Chronic Insomnia Therapeutic Assessment: Chronic Insomnia current marketed and Chronic Insomnia emerging therapies

Chronic Insomnia Market Dynamics: Chronic Insomnia market drivers and Chronic Insomnia market barriers
Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter’s five forces, BCG Matrix, Market entry strategies

Chronic Insomnia Unmet Needs, KOL’s views, Analyst’s views, Chronic Insomnia Market Access and Reimbursement

To know more about Chronic Insomnia companies working in the treatment market, visit @ Chronic Insomnia Clinical Trials and Therapeutic Assessment

Table of Contents
1. Chronic Insomnia Market Report Introduction
2. Executive Summary for Chronic Insomnia
3. SWOT analysis of Chronic Insomnia
4. Chronic Insomnia Patient Share (%) Overview at a Glance
5. Chronic Insomnia Market Overview at a Glance
6. Chronic Insomnia Disease Background and Overview
7. Chronic Insomnia Epidemiology and Patient Population
8. Country-Specific Patient Population of Chronic Insomnia
9. Chronic Insomnia Current Treatment and Medical Practices
10. Chronic Insomnia Unmet Needs
11. Chronic Insomnia Emerging Therapies
12. Chronic Insomnia Market Outlook
13. Country-Wise Chronic Insomnia Market Analysis (2019–2032)
14. Chronic Insomnia Market Access and Reimbursement of Therapies
15. Chronic Insomnia Market Drivers
16. Chronic Insomnia Market Barriers
17. Chronic Insomnia Appendix
18. Chronic Insomnia Report Methodology
19. DelveInsight Capabilities
20. Disclaimer
21. About DelveInsight

About DelveInsight
DelveInsight is a leading Healthcare Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.
It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate the business growth and overcome challenges with a practical approach.

Gaurav Bora
DelveInsight Business Research
+1 469-945-7679
email us here

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.